Active Pharmaceutical Ingredients Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Active Pharmaceutical Ingredients stocks.

Active Pharmaceutical Ingredients Stocks Recent News

Date Stock Title
May 31 NVS Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
May 31 NVS Novartis boasts Scemblix beats tyrosine kinase inhibitors for chronic myeloid leukemia
May 31 NVS Novartis reports positive Phase 3 data for remibrutinib for chronic hives
May 31 NVS Novartis' Oral Drug For Chronic Skin Disease Candidate Shows Efficacy, Long-term Safety
May 31 OPK OPKO Health to Participate in the Jefferies Global Healthcare Conference
May 31 NVS Novartis Scemblix® Phase III data first to show superior efficacy with a favorable safety and tolerability profile vs. standard-of-care TKIs in adults with newly diagnosed CML
May 31 VTRS Viatris to Participate in the Jeffries Global Healthcare Conference
May 31 NVS Novartis reports Phase III data for trials of remibrutinib to treat CSU
May 31 NVS Novartis study points to larger role for targeted leukemia drug
May 30 VTRS Viatris: Skeptics Proven Right Once Again
May 30 NVS Novartis Phase III data confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria
May 30 NVS Novartis ending development of phase 3 KRAS lung cancer drug - report
May 30 NVS Why Is Lilly (LLY) Up 4.5% Since Last Earnings Report?
May 30 PRGO 3 Underrated Dividend Stocks Worth Your Attention — 'Unknown' But High Yield Potential
May 30 TEVA Teva wins FDA nod for new Austedo formulation
May 30 TEVA FDA approves Teva Pharmaceuticals’ AUSTEDO XR for TD and HD chorea
May 30 AMPH Amphastar Pharmaceuticals: Buy When Fear Is Overblown
May 29 TEVA Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)
May 29 VTRS Insider Sale: Chief Legal Officer Brian Roman Sells 89,419 Shares of Viatris Inc (VTRS)
May 28 RDY Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America
Active Pharmaceutical Ingredients

An active ingredient (AI) is the ingredient in a pharmaceutical drug or pesticide that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon (from Greek: φάρμακον, adapted from pharmacos) which originally denoted a magical substance or drug.
The terms active constituent or active principle are often chosen when referring to the active substance of interest in a plant (such as salicylic acid in willow bark or arecoline in areca nuts), because the word ingredient in many minds connotes a sense of human agency (that is, something that a person combines with other substances), whereas the natural products present in plants were not added by any human agency but rather occurred naturally ("a plant doesn't have ingredients").
In contrast with the active ingredients, the inactive ingredients are usually called excipients in pharmaceutical contexts. The main excipient that serves as a medium for conveying the active ingredient is usually called the vehicle. Petrolatum and mineral oil are common vehicles.

Browse All Tags